Expert Q&A: COVID-19 Vaccine Trials and Immunocompromised Patients
A vaccine expert explains how patients are recruited for COVID-19 vaccine trials, including those who are immunocompromised.
Expert Q&A: COVID-19 Vaccine Trials and Immunocompromised Patients
Vaccine Expert Insights
Wilbur Chen, MD, MS, Chief of the Adult Clinical Studies, Center for Vaccine Development and Global Health University of Maryland, shares key issues to consider for the COVID-19 vaccine trials and immunocompromised patients.